Literature DB >> 18495113

Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.

Xiaoou Sun1, Matthias Becker, Kristin Pankow, Eberhard Krause, Martina Ringling, Michael Beyermann, Bjoern Maul, Thomas Walther, Wolf-Eberhard Siems.   

Abstract

Catabolic processes play a crucial role in the steady state of the amyloid-beta peptide (Abeta). Neprilysin (NEP) and angiotensin-converting enzyme (ACE), two transmembranal enzymes with greatest importance in peptide pharmacology, are known to play a role in Abeta catabolism. This paper focuses on the N-terminal part of Abeta. This region contains the three amino acid residues that determine the differences between human (hAbeta) and murine Abeta (mAbeta). Moreover, the N-terminal part of Abeta contains the zinc-binding site of the molecule. Consequently, all hydrolytic attacks on this part of the Alzheimer peptide should be of exceptional interest. We investigated domain-selective forms of ACE in HPLC-monitored peptide degradation studies and used mass spectrometry for product analyses. We found that ACE-evoked a hydrolysis of the N-terminal part of m- and hAbeta. The hAbeta sequence hAbeta (4-15) was found to be a better substrate for ACE compared to the corresponding murine form. Moreover, we localized the corresponding cleavage sites in the N-terminal part of Abeta as well as in the full-length molecule and identified new sites of endopeptidolytic attack by ACE. Finally, we demonstrate that both catalytic domains of mACE have similar hydrolytic activity on the N-terminal part of Abeta. Our results show that ACE besides its typical function as a dipeptidyl-carboxypeptidase has also unequivocal endopeptidolytic activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495113     DOI: 10.1016/j.ejphar.2008.03.058

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

Authors:  Linda Ferrington; Laura E Palmer; Seth Love; Karen J Horsburgh; Paul At Kelly; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2012-04-12       Impact factor: 4.060

2.  Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Linda Ferrington; J Scott Miners; Laura E Palmer; Susan M Bond; Joanne E Povey; Paul At Kelly; Seth Love; Karen J Horsburgh; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2011-02-05       Impact factor: 4.060

Review 3.  ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.

Authors:  Maya Koronyo-Hamaoui; Kandarp Shah; Yosef Koronyo; Ellen Bernstein; Jorge F Giani; Tea Janjulia; Keith L Black; Peng D Shi; Romer A Gonzalez-Villalobos; Sebastien Fuchs; Xiao Z Shen; Kenneth E Bernstein
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 4.  Angiotensin-converting enzyme in innate and adaptive immunity.

Authors:  Kenneth E Bernstein; Zakir Khan; Jorge F Giani; Duo-Yao Cao; Ellen A Bernstein; Xiao Z Shen
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

5.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

6.  ACE variants and association with brain Aβ levels in Alzheimer's disease.

Authors:  J Scott Miners; Zoë van Helmond; Merryn Raiker; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2010-10-15       Impact factor: 4.060

7.  acn-1, a C. elegans homologue of ACE, genetically interacts with the let-7 microRNA and other heterochronic genes.

Authors:  Chanatip Metheetrairut; Yuri Ahuja; Frank J Slack
Journal:  Cell Cycle       Date:  2017-09-21       Impact factor: 4.534

Review 8.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

9.  An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.

Authors:  Todd L Edwards; Margaret Pericak-Vance; Johnny R Gilbert; Jonathan L Haines; Eden R Martin; Marylyn D Ritchie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

10.  Angiotensins and Alzheimer's disease: a bench to bedside overview.

Authors:  Patrick G Kehoe
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.